Sleep Disorders Clinical Trials

This study will evaluate the efficacy of cyclobenzaprine in the treatment of military-related PTSD. The study is randomized and double-blind, meaning both the participant and the tester are unaware which group is receiving the experimental and placebo treatments. The study will last approximately 12 weeks. Participants take the study drug ...

This is a study to test the safety and tolerability of the research study drug, suvorexant and test the effects of suvorexant compared to placebo in improving insomnia in subjects with mild to moderate Alzheimer’s disease.

The purpose of this research study is to examine the tolerability and effectiveness of an investigational medication for excessive sleepiness associated with shift worker disorder. This study is comprised of 1 office visit, 6-8 overnight/next day stays in our sleep lab and a follow-up phone call (about 30 days after ...

  The purpose of this research study is to assess the safety and tolerability of an investigational medication foe insomnia compared with zolpidem and placebo in subjects with insomnia disorder. This study is comprised of 2 office visits, 6 overnight stays, and one phone call over approximately 2 months. The ...

This study is a 4-week, multicenter, randomized, double-blind, placebo-controlled, ascending dose, 4-period crossover study designed to evaluate the safety, tolerability, efficacy, and PK of JZP-110 (75, 150, and 300 mg) in the treatment of excessive sleepiness in adult subjects with idiopathic PD.

Outpatient study designed to test a new investigational medication in adults 50 years and older with insomnia. Compensation is $1450. To qualify, you must be 50 years and older. Length of study: 4-6 weeks Overnight visits: 5 Total number of outpatient visits: 6 For more information,

A double-blind randomized, placebo-controlled, 30 night polysomnographic study of an investigational medication in adults 18 and older with primary insomnia. To qualify, you must be: 18 years and older Length of study: 6 weeks Overnight visits: 10 Total number of outpatient visits: 1 For more information,

If so, and you are between 18 – 64 years of age, You may qualify to participate in a clinical research study to help people improve their sleep problem. Qualified participants will receive free of charge, study related: Physical exams Study medication You may be compensated for your time and ...

The purpose of this study is to evaluate the safety and effectiveness of an FDA-approved study drug as a sleep aid as compared to placebo (an inactive substance) in the treatment of insomnia associated with interferon-induced insomnia in patients with chronic hepatitis C (CHC). In addition, another purpose of this ...

People with post-traumatic stress disorder are asked to participate in a research study being conducted by Montefiore Medical Center.